Vivosim Lab Inc (VIVS) Stock Price, Quote & News

Company Profile

VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicology insights through its new approach methodologies (NAM) models; and bespoke services in the areas of investigational toxicology, mechanism of drug action elucidation, and other applications of complex human tissue models. The company also provides liver toxicolo...

Industry: Biotechnology

Sector: Healthcare

Phone: 858 224 1000

Website: vivosim.ai

Address:

11555 Sorrento Valley Road, Suite 100, San Diego, United States

Zeestallion Jul. 27 at 9:47 PM

$VIVS Let the market find this and see what I 👀 🚢🚀. $DFNS Broke$20.00 😱 this is what I mean we get in early! 🤑💰👇 Added VIVS for an epic reversal 🚢🚀🔥 Here's why 👇 screenshot 🚀 $VEEE $NUAI $DRUG

0 · Reply

Zeestallion Jul. 27 at 9:27 PM

$VIVS You can't ignore this 🚢🚢🚀💪🚀 Over 500%+ PROJECTED REVENUE GROWTH. Added VIVS here's why 👇 $FIEE $DFNS $NUAI $DRUG

1 · Reply

Zeestallion Jul. 27 at 8:56 PM

$VIVS 500%+ PROJECTED REVENUE GROWTH! We get in early 🚢🚀 You can't ignore this 🚢 $DRUG We got in early you can see from screenshot below 👇💰🤑 Added VIVS for an epic reversal 🚢🚀 Here's why 👇 screenshot $DFNS $INLF $OPK

0 · Reply

Xander1989 Jul. 27 at 8:39 PM

$BIYA $SHIB.X $TSLA $VIVS $WBUY Move all gains to BIYA 🐇🚀

0 · Reply

Xander1989 Jul. 27 at 8:38 PM

$VIVS 🫵🤡s lol short them to the end … $WBUY $SHIB.X $TSLA $BIYA

0 · Reply

kolinr11 Jul. 27 at 8:31 PM

$DFNS $GOSS $VIVS $SXTC Load up. this weeks play!!

1 · Reply

Zeestallion Jul. 27 at 8:25 PM

$VIVS 500%+ PROJECTED REVENUE GROWTH 🚢🚢 $NUAI We got in early you can see below screenshot 👇🤑💰 Added VIVS for an epic reversal 🚢🚀 Here's why 👇 screenshot $DFNS $BIYA $INLF

0 · Reply

Zboquid Jul. 27 at 7:49 PM

$VIVS Another genius

1 · Reply

PLATINUM_TRADES Jul. 27 at 7:28 PM

$VIVS This is funny.. They lost big now they bash it 🤣 newbies will never know how to make money.. $10? 😂 Dream land... I'll take $1.00 but $10? Now u know why

0 · Reply

Zboquid Jul. 27 at 7:12 PM

$VIVS Bag holder post are the best! 🤣

0 · Reply

VivoSim enters China with first commercial sales of NAMkind testing services

Jul 21, 2026, 8:05 AM EDT - 6 days ago

VivoSim Enters China with First Commercial Sales of NAMkind™ Toxicology Screening and Efficacy Testing Services

Jul 16, 2026, 8:30 AM EDT - 11 days ago

VivoSim Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Healthcare Focused Institutional Investor

2026-07-15T13:16:57.000Z - 12 days ago

Why Is Penny Stock VivoSim Labs (VIVS) Up Today?

LLY

2026-07-15T12:51:36.000Z - 12 days ago

VivoSim receives $5M milestone payment from Eli Lilly

LLY

2026-07-15T12:51:24.000Z - 12 days ago

VivoSim sees FY27 revenue up over 500%

Jul 15, 2026, 8:05 AM EDT - 12 days ago

VivoSim Receives $5M Milestone Payment from Eli Lilly; Provides Guidance That It Expects Revenue Growth of 500%+ in FY2027

Jun 29, 2026, 8:05 AM EDT - 4 weeks ago

VivoSim Presents Data Showing Superiority to Competition in NAM Liver Tox Prediction at European Toxicology Meeting

Apr 28, 2026, 8:05 AM EDT - 3 months ago

VivoSim Platform Predicts Gastrointestinal Toxicity (Diarrhea) in an AI Model Trained on Human Intestinal Model Results – Without Animal Testing

Apr 1, 2026, 8:05 AM EDT - 4 months ago

VivoSim Announces Pricing of up to a $4 Million Public Offering

Mar 24, 2026, 8:05 AM EDT - 4 months ago

VivoSim Releases Antibody Drug Conjugate (ADC) Data Showing Power to Detect ADC Toxicity and Guide Design of Safer ADCs

2026-03-03T13:34:44.000Z - 5 months ago

VivoSim appoints Arumugham Raghunathan as VP, global sales

Mar 3, 2026, 8:05 AM EST - 5 months ago

VivoSim Appoints Arumugham (Ragoo) Raghunathan as Vice President of Global Sales

2026-02-11T13:22:48.000Z - 5 months ago

VivoSim to debut antibody drug conjugate data at SOT meeting

Feb 11, 2026, 8:05 AM EST - 5 months ago

VivoSim to Debut Antibody Drug Conjugate Data, representing a major new market for NAMkind models, at Society of Toxicology Meeting in San Diego

Jan 29, 2026, 4:05 PM EST - 6 months ago

VivoSim Expands Asia-Pacific Access to NAMKind™ Human-Based Toxicology Services Through New Distributor Agreement in Korea and China

2026-01-06T13:36:13.000Z - 7 months ago

VivoSim appoints Sethi as Chief Scientific Officer

Jan 6, 2026, 8:05 AM EST - 7 months ago

VivoSim Labs Appoints Amar Sethi, M.D., Ph.D. as Chief Scientific Officer

2025-08-14T12:15:09.000Z - 1 year ago

VivoSim appoints Lialin as Chief Commercial Officer

Aug 14, 2025, 8:05 AM EDT - 1 year ago

VivoSim Labs Appoints Tony Lialin as Chief Commercial Officer

May 13, 2025, 8:05 AM EDT - 1 year ago

VivoSim's NAMKind™ Intestine Wins Blue Ribbon Award at Digestive Disease Week Conference

2025-05-07T12:27:34.000Z - 1 year ago

VivoSim NAMkind platform featured in presentation at DDW

May 7, 2025, 8:05 AM EDT - 1 year ago

VivoSim Presents Best-in-Class Liver Toxicology Prediction Results at Digestive Disease Week Conference

Apr 24, 2025, 8:05 AM EDT - 1 year ago

VivoSim Announces Emergence from Stealth Mode To Provide Technologies for FDA Turn Away from Animal Models, $10B+ Market

Apr 23, 2025, 8:05 AM EDT - 1 year ago

VivoSim to Carry Forward Organovo 3D Bioprinting

Apr 2, 2025, 8:05 AM EDT - 1 year ago

Organovo Provides Update on Cash and Nasdaq Continued Listing Requirements

Mar 27, 2025, 8:05 AM EDT - 1 year ago

Organovo Provides Business Update

Mar 25, 2025, 11:25 AM EDT - 1 year ago

Organovo Announces Close of the Sale of FXR Program to Eli Lilly and Company

LLY

Mar 19, 2025, 8:05 AM EDT - 1 year ago

Organovo Announces Reverse Stock Split

Mar 11, 2025, 7:00 AM EDT - 1 year ago

Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors

GRCE MTNB

Mar 6, 2025, 8:05 AM EST - 1 year ago

Organovo Announces the Issuance of Additional Shares in Conjunction with Warrant Exercises

Feb 25, 2025, 8:05 AM EST - 1 year ago

Organovo's FXR Program, including FXR314, to Be Acquired by Eli Lilly and Company

Jan 6, 2025, 8:05 AM EST - 1 year ago

Organovo Announces Appointment of Norman Staskey as Chief Financial Officer

Nov 20, 2024, 8:05 AM EST - 1 year ago

Organovo Presents Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver Meeting

Nov 13, 2024, 8:06 AM EST - 1 year ago

Organovo to Present Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver Meeting Sponsored by the American Association for the Study of Liver Diseases

Jul 16, 2024, 8:05 AM EDT - 2 years ago

Organovo Highlights FXR314 Near Term Value Catalysts at Jones Trading Conference Strong Preclinical and Human Rationale for FXR314 in P2 2 Ulcerative Colitis

May 21, 2024, 8:05 AM EDT - 2 years ago

Organovo Data Presented at Digestive Disease Week (DDW2024) Demonstrating Potential for FXR314 as Combination Therapy with Tofacitinib for Inflammatory Bowel Disease

May 14, 2024, 11:00 AM EDT - 2 years ago

Organovo to Present Data on FXR314 at Digestive Diseases Week (DDW2024)

May 8, 2024, 8:00 PM EDT - 2 years ago

Organovo Holdings, Inc. Announces Pricing of $5.25 Million Public Offering

Apr 15, 2024, 8:28 AM EDT - 2 years ago

Organovo's fatty liver disease drug meets main goal in mid-stage study

Apr 15, 2024, 8:05 AM EDT - 2 years ago

Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to Placebo

Jan 25, 2024, 8:05 AM EST - 2 years ago

Organovo Presents FXR314 3D Human Tissue Model Findings That Show Improved Epithelial Barrier Function and Fibrosis Reduction at Crohn's and Colitis Congress

Jan 9, 2024, 8:05 AM EST - 2 years ago

Organovo To Present FXR314 IBD 3D Model Findings at Upcoming Crohn's and Colitis Congress

Dec 6, 2023, 8:05 AM EST - 2 years ago

Organovo Provides Timing for Release of FXR314 Phase 2 NASH Results

Nov 13, 2023, 8:05 AM EST - 2 years ago

CORRECTION – Organovo Highlights FXR314 Combination Therapy Potential and Plan

Nov 8, 2023, 8:05 AM EST - 2 years ago

Organovo Highlights FXR314 Combination Therapy Potential and Plan

Sep 8, 2023, 12:46 PM EDT - 3 years ago

Organovo to Participate in the H.C. Wainwright Global Investment Conference

Aug 23, 2023, 8:05 AM EDT - 3 years ago

Organovo Advances Clinical Timelines for FXR314 and Provides Updates on NASH Phase 2 Data

Mar 21, 2023, 8:05 AM EDT - 3 years ago

Organovo Announces FXR Program

Nov 15, 2022, 8:05 AM EST - 4 years ago

Organovo Announces Target Validation Ahead of Schedule, Accelerating Timeline for First Crohn's Disease Drug Candidates

Sep 6, 2022, 8:20 AM EDT - 4 years ago

Organovo to Participate in the H.C. Wainwright 24th Annual Global Investment Conference

Sep 6, 2022, 8:05 AM EDT - 4 years ago

Organovo Announces Postponement of Annual Meeting of Stockholders

May 17, 2022, 8:05 AM EDT - 4 years ago

Organovo Achieves 3D Tissue Model for Crohn's Disease

Mar 1, 2022, 8:05 AM EST - 4 years ago

UPDATE -- Organovo and BICO (CELLINK) Reach Licensing Agreement on Bioprinting Patents

Feb 23, 2022, 8:05 AM EST - 4 years ago

Organovo and BICO (CELLINK) Reach Licensing Agreement on Bioprinting Patents

Feb 18, 2022, 4:00 PM EST - 4 years ago

Organovo Holdings, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Feb 18, 2022, 1:00 PM EST - 4 years ago

Organovo Welcomes New Sr. Vice President of Strategy and Business Development

Feb 2, 2022, 12:00 PM EST - 4 years ago

Organovo Guides on Patent Portfolio and Successful IPR Defense of Two Patents

Jan 10, 2022, 12:00 PM EST - 4 years ago

Organovo Files Counterclaims In Patent Lawsuit Brought Against It by CellInk

Zeestallion Jul. 27 at 9:47 PM

0 · Reply

Zeestallion Jul. 27 at 9:27 PM

$VIVS You can't ignore this 🚢🚢🚀💪🚀 Over 500%+ PROJECTED REVENUE GROWTH. Added VIVS here's why 👇 $FIEE $DFNS $NUAI $DRUG

1 · Reply

Zeestallion Jul. 27 at 8:56 PM

0 · Reply

Xander1989 Jul. 27 at 8:39 PM

$BIYA $SHIB.X $TSLA $VIVS $WBUY Move all gains to BIYA 🐇🚀

0 · Reply

Xander1989 Jul. 27 at 8:38 PM

$VIVS 🫵🤡s lol short them to the end … $WBUY $SHIB.X $TSLA $BIYA

0 · Reply

kolinr11 Jul. 27 at 8:31 PM

$DFNS $GOSS $VIVS $SXTC Load up. this weeks play!!

1 · Reply

Zeestallion Jul. 27 at 8:25 PM

$VIVS 500%+ PROJECTED REVENUE GROWTH 🚢🚢 $NUAI We got in early you can see below screenshot 👇🤑💰 Added VIVS for an epic reversal 🚢🚀 Here's why 👇 screenshot $DFNS $BIYA $INLF

0 · Reply

Zboquid Jul. 27 at 7:49 PM

$VIVS Another genius

1 · Reply

PLATINUM_TRADES Jul. 27 at 7:28 PM

$VIVS This is funny.. They lost big now they bash it 🤣 newbies will never know how to make money.. $10? 😂 Dream land... I'll take $1.00 but $10? Now u know why

0 · Reply

Zboquid Jul. 27 at 7:12 PM

$VIVS Bag holder post are the best! 🤣

0 · Reply

doctorslopadopolis Jul. 27 at 6:54 PM

$VIVS

0 · Reply

Zeestallion Jul. 27 at 6:53 PM

$VIVS 500%+ PROJECTED REVENUE GROWTH 🚢🚢🚀🚀 $WLDS This is what I mean early 🤑💰👇 screenshot Added VIVS for an epic reversal 🚢 Here's why 👇 screenshot $FIEE $BIYA $LVWR

0 · Reply

Xander1989 Jul. 27 at 6:38 PM

$VIVS $SPY $QQQ $NVDA $AAPL

0 · Reply

Zeestallion Jul. 27 at 6:00 PM

$VIVS 🚢🚢🚀🔥 $DFNS $FIEE $BIYA $ENTX

0 · Reply

Staker58 Jul. 27 at 5:53 PM

$VIVS only a matter of time before explosion

0 · Reply

Zeestallion Jul. 27 at 5:32 PM

$VIVS 500+% projected revenue growth 🚢🚢🚀🚀 $DFNS We got in early as you can see below in the screenshot 👇💰🤑 Added VIVS for an epic reversal 🔥🚀 Here's why 👇 screenshot $DFNS $BIYA $FIEE

0 · Reply

Xander1989 Jul. 27 at 4:45 PM

$AMC $BIYA $DFNS $SXTC $VIVS you shouldve held biya

0 · Reply

Zeestallion Jul. 27 at 4:34 PM

$VIVS 500%+ Projected Revenue Growth 🔥🚀 $PN We got in early as you can see below 🤑💰 screenshot. Added VIVS for an epic reversal 🚢 Here's why 👇 screenshot $DFNS $FIEE $BIYA

0 · Reply

CraftWerk Jul. 27 at 4:11 PM

$VIVS I am in shock they have not announced the closing of the offering. No follow up PR that it was closed. "The closing of the offering is expected to occur on or about July 17, 2026" https://finance.yahoo.com/healthcare/articles/vivosim-announces-pricing-4-0-123000894.html

0 · Reply

Zeestallion Jul. 27 at 4:09 PM

$VIVS 🚢🚢 Get in early 🚢🚢🚀🚀 $PN We got in early hit $10.00 💰🤑👇 screenshot. Added VIVS here's why for an epic reversal 👇 $DFNS $ENTX $LVWR

1 · Reply

Zeestallion Jul. 27 at 3:32 PM

$VIVS Company project 500% in revenue growth. Get in early before 🚢🚢🚀🚀 $PN We got in early screenshot 💰🤑👇 Now added VIVS here's why 👇 $FIEE $BIYA $LVWR

0 · Reply

BigJuanOTC Jul. 27 at 3:17 PM

$VIVS The price action here is getting absurd…. give us a solid pr

0 · Reply

Market Cap	1.46M
Revenue (ttm)	130,000.00
Net Income (ttm)	-13.84M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-10,646.15%
Debt to Equity Ratio	0.00

Volume	1,296,844
Avg Vol	4,184,538
Day's Range	N/A - N/A
Shares Out	3.49M
Stochastic %K	1%
Beta	1.40
Analysts	Strong Buy
Price Target	$64.83